Ataxia-telangiectasia: Without ataxia or telangiectasia?

Neurology

Volumn 73, Issue 6, 2009, Pages 414-415

  Saunders Pullman, Rachel J ^a,b   Gatti, Richard ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APRAXIA; ATAXIA TELANGIECTASIA; BLOOD LEVEL; BREAST CANCER; CEREBELLUM; CHOREOATHETOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DYSTONIA; EDITORIAL; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; HYPOPHYSIS TUMOR; IMMUNOBLOTTING; KARYOTYPING; MEDICAL RECORD; MISSENSE MUTATION; MOTOR DYSFUNCTION; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCREENING TEST; SENSORIMOTOR NEUROPATHY; TREMOR;

EID: 69449091556     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181b39140     Document Type: Editorial

References (10)

1. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair 2004;3:1187-1196.
2. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;412:499-506.
3. Segwick RP, Boder E. Ataxia telangiectasia. In: Vinken VJ, Bruyn SW, de Jong JMBV, eds. Handbook of Clinical Neurology, Vol 60: Hereditary Neuropathies and Spino-cerebellar Atrophies. New York: Elsevier Science; 1991:347-393.
4. Dork T, Bendix-Walters R, Wegner RD, Stumm M. Slow progression of ataxia-telangiectasia with double missense and in frame splice mutations. Am J Med Genet A 2004;126A:272-277. (Pubitemid 38420639)
5. Alterman N, Fattal-Valevski A, Moyal L, et al. Ataxia-telangiectasia: mild neurologic presentation despite null ATM mutation and severe cellular phenotype. Am J Med Genet A 2007;143A:1827-1834. (Pubitemid 47206057)
6. Verhagen MMM, Abdo WF, Willemsen MAAP, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 2009;73:430-437.
7. Chun HH, Sun X, Nahas SA, et al. Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Mol Genet Metab 2003;80:437-443. (Pubitemid 37491205)
8. Nahas SA, Butch AW, Du L, Gatti RA. Rapid flow cytometry-based structural maintenance of chromosomes 1 (SMC1) phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes. Clin Chem 2009;55:463-472.
9. Coutinho G, Mitui M, Campbell C, et al. Five haplotypes account for fifty-five percent of ATM mutations in Brazilian patients with ataxia-telangiectasia: seven new mutations. Am J Med Genet A 2004;126A:33-40. (Pubitemid 38436470)
10. Mitui M, Nahas SA, Du LT, et al. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk. Hum Mutat 2009;30:12-21.